化合物简介
LY-334370 is a selective 5-HT1F receptor agonist which was under development by Eli Lilly and Company for the treatment of migraine headaches. The drug showed efficacy in a phase II clinical trial but further development was halted due to toxicity detected in animals.
基本信息
中文名称
4-氟-N-(3-(1-甲基哌啶-4-基)-1H-吲哚-5-基)苯甲酰胺盐酸盐
英文名称
4-fluoro-N-[3-(1-methylpiperidin-4-yl)-1H-indol-5-yl]benzamide
中文别名
英文别名
CAS号
182563-08-2
分子式
C21H23ClFN3O
分子量
387.878
精确质量
387.151
PSA
48.13
LOGP
5.1814
编号系统
UNII
5Q7I1WL2UY
物化性质
沸点
504.1ºC at 760 mmHg
闪点
258.7ºC
合成路线